BGC-200761

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameBGC-200761
Drug Alias NameBGC20-0761BGC-20-761
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 6 (5-HT6) receptor antagonistsSerotonin 2a (5-HT2a) receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 6 (5-HT6) receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBoston Scientific Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoston Scientific Corp
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A